Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate for Inflammation Following Ocular Surgery
NCT00616070Phase 3Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Start
- Dec 2007
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of difluprednate in post-operative ocular inflammation, sponsored by Sirion Therapeutics, Inc.. Started Dec 2007; status: completed.
02
Drugs
difluprednate
03
Conditions
post-operative ocular inflammation
Beyond the preview
Go deeper on NCT00616070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616070.